We upgrade our call on ViTrox Corp (ViTrox) to BUY from HOLD with an unchanged FV of RM8.40/share based on a higher PE of 41x (from 36x), +1 std deviation above the 5- year mean of 32x on a revised FY24F EPS. The higher PE is premised on our anticipation of a continued gradual recovery for the semiconductor industry in FY24. We ascribe an unchanged 4-star ESG rating which incorporates a 3% premium to our valuation (Exhibit 4).
We lower our FY23-FY25F earnings by 12% for each year, assuming more conservative sales estimates, after the group’s 9MFY23 results fell short of expectation. 9MFY23 core net profit of RM108mil only accounted for 64% of both our and consensus FY23F projection.
YoY, 9MFY23 revenue slipped by 23%, mainly attributed to lower demand from machine vision system (MVS) and automated board inspection (ABI) segments as a result of the global economic slowdown and slower recovery in the semiconductor industry. 9MFY23 core net profit declined by 33% YoY in tandem with lower revenue and EBITDA margin decline of 200bps to 28%.
QoQ, revenue in 3QFY23 was flattish. However, 3QFY23 core net profit rose by 21%, which we believe is likely due to a better product mix.
Despite the weaker reported earnings, we are comforted by the group's well-diversified revenue base and its exposure to high-growth industries such as computing, telecommunication and automotive segments, which are its bright spots. We anticipate a gradual recovery and stronger demand in 1QFY24 from Automated Board Inspection (ABI) and Machine Vision System (MVS) segments compared to 2HFY23.
Additionally, ViTrox's geographical diversity may play a crucial role in capturing new customers arising from trade diversion due to the US-China chip war, particularly in Mexico and the ASEAN region.
From a valuation perspective, the stock currently trades at an attractive FY24F PE of 36x vs its 5-year peak of over 66x.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....